首页>
外国专利>
PHARMACEUTICAL COMPOSITION CONTAINING EPERISONE WITH IMPROVED STABILITY OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND A PREDETERMINED ACIDIFIER
PHARMACEUTICAL COMPOSITION CONTAINING EPERISONE WITH IMPROVED STABILITY OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND A PREDETERMINED ACIDIFIER
展开▼
机译:包含具有增强的稳定性或其药学上可接受的盐的依匹松的药物组合物,以及预定的酸化剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
PURPOSE: A pharmaceutical composition containing eperisone with improved stability or a pharmaceutically acceptable salt thereof, and a predetermined acidifier is provided to effectively suppress the generation of related materials by adding the predetermined acidifier and to enable long-term maintenance of drug efficacy, thereby being applied to a pharmaceutical industry.;CONSTITUTION: A pharmaceutical composition contains eperisone or a pharmaceutically acceptable salt thereof, an acidifier, and a pharmaceutically acceptable excipient. Eperisone or the pharmaceutically acceptable salt is eperisone hydrochloride. The pH concentration of the pharmaceutical composition is pH 1-5 when the pharmaceutical composition is dissolved or dispersed in 10-20 mL of water. The acidifier is selected among organic acids and a mixture thereof. The organic acids are selected among alginic acid, phosphoric acid, sulfuric acid, hydrochloric acid, boric acid, hydrobromic acid, and a mixture thereof. The pharmaceutically acceptable excipient is selected among a dispersing agent, a disintegrant, a binder, a lubricant, and a mixture thereof.;COPYRIGHT KIPO 2013;[Reference numerals] (AA) Acceleration condition; (BB) Related material; (C1) Example 1; (C2) Example 2; (DD) Comparative example 1
展开▼